Potential for erroneous results indicating resistance when using the bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide

Journal of Clinical Microbiology

Volumn 48, Issue 1, 2010, Pages 300-301

  Chedore, Pamela ^a   Bertucci, Lina ^a   Wolfe, Joyce ^b   Sharma, Meenu ^b   Jamieson, Frances ^a  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b Canadian Science Centre for Human and Animal Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PYRAZINAMIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE MUTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NOTE; PNCA GENE; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; DIAGNOSTIC ERRORS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE;

MYCOBACTERIUM TUBERCULOSIS;

EID: 73949160000     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01775-09     Document Type: Note

References (15)

1. Aono, A., K. Hirano, S. Hamasaki, and C. Abe. 2002. Evaluation of BACTEC MGIT 960 PZA medium for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide (PZA): compared with the results of pyrazinamidase assay and Kypkuto PZA test. Diagn. Microbiol. Infect. Dis. 44:347-352.
2. Becton Dickinson and Company. 1999. Bactec MGIT 960 system user's manual. Becton Dickinson and Company, Sparks, MD.
3. Clark, R. B., M. A. Lewinski, M. J. Loeffelholz, and R. J. Tibbetts. 2009. Cumitech 31A, Verification and validation of procedures in the clinical microbiology laboratory, p 14. Coordinating ed., S. E. Sharp. ASM Press, Washington, DC.
4. CLSI/NCCLS. 2003. Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic Actinomycetes, vol. 23, no. 18. Approved standard M24-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
5. Davies, A. P., O. J. Billington, T. D. McHugh, D. A. Mitchison, and S. H. Gillespie. 2000. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis. J. Clin. Microbiol. 38:3686-3688.
6. Kontos, F., S. Nicolaou, C. Kostopoulos, Z. Gitti, E. Petinaki, M. Maniati, and S. Anagnostou. 2003. Multicenter evaluation of the fully automated Bactec MGIT 960 system for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide: comparison with the radiometric Bactec 460TB system. J. Microbiol. Methods 55:331-333.
7. Mestdagh, M., P. A. Fonteyne, L. Realini, R. Rossau, et al. 1999. Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43:2317-2319.
8. Morlock, G. P., J. T. Crawford, W. R. Butler, S. E. Brim, D. Sikes, G. H. Mazurek, C. L. Woodley, and R. C. Cooksey. 2000. Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44:2291-2295.
9. Parsons, L., A. Somoskovi, R. Urbanczik, and M. Salfinger. 2004. Laboratory diagnostic aspects of drug-resistant tuberculosis. Front. Biosci. 9:2086-2105.
10. Pfyffer, G. E., F. Palicova, and S. Rüsch-Gerdes. 2002. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 System. J. Clin. Microbiol. 40:1670-1674.
11. Scarparo, C., P. Ricordi, G. Ruggiero, and P. Piccoli. 2004. Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method. J. Clin. Microbiol. 42:1109-1114.
12. Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamidase/ nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2:662-667.
13. Siddiqi, S. H. 1989. BACTEC TB system, product and procedure manual. Becton Dickinson Diagnostic Instruments Systems, Towson, MD.
14. Wayne, L. G. 1974. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am. Rev. Respir. Dis. 109:147-151.
15. Zhang, Y., S. Permar, and Z. Sun. 2002. Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. J. Med. Microbiol. 51:42-49.